Renalytix Plc (RNLXY)
OTCMKTS
· Delayed Price · Currency is USD
0.2000
+0.0200 (11.11%)
Jun 18, 2025, 4:00 PM EDT
Renalytix Revenue
Renalytix had revenue of $1.25M in the quarter ending December 31, 2024, with 76.45% growth. This brings the company's revenue in the last twelve months to $2.89M, up 20.08% year-over-year. In the fiscal year ending June 30, 2024, Renalytix had annual revenue of $2.29M, down -32.74%.
Revenue (ttm)
2.89M
Revenue Growth
+20.08%
P/S Ratio
11.18
Revenue / Employee
28.37K
Employees
102
Market Cap
32.35M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo, Inc. | 1.73B |
| Veradigm | 588.02M |
| Elite Pharmaceuticals | 70.00M |
| Tian'an Technology Group | 1.78M |
| American Oncology Network | 1.76B |
| Glass House Brands | 215.62M |
| Northwest Biotherapeutics | 1.47M |
| Silence Therapeutics | 27.70M |
Renalytix News
- 3 months ago - Renalytix Plc (RNLXY) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 7 months ago - Renalytix plc Reports Financial Results for First Quarter of Fiscal Year 2025 - PRNewsWire